ArticleJTO clinical and research reports2025

Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study.

Li Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.